Home/Filings/4/0000899243-19-025628
4//SEC Filing

Agresta Samuel 4

Accession 0000899243-19-025628

CIK 0001113148other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 7:18 PM ET

Size

5.6 KB

Accession

0000899243-19-025628

Insider Transaction Report

Form 4
Period: 2019-10-16
Agresta Samuel
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-10-16+60,00060,000 total
    Exercise: $1.14Exp: 2030-10-16Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/8th of the shares on December 31, 2019 and as to 1/8th of the shares at the end of each calendar quarter thereafter, provided that the holder continues to serve as a director of the Issuer.

Issuer

INFINITY PHARMACEUTICALS, INC.

CIK 0001113148

Entity typeother

Related Parties

1
  • filerCIK 0001748961

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 7:18 PM ET
Size
5.6 KB